Search Results - "SHAUGHNESSY, Paul"

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation by Soiffer, Robert J, Kim, Haesook T, McGuirk, Joseph, Horwitz, Mitchell E, Johnston, Laura, Patnaik, Mrinal M, Rybka, Witold, Artz, Andrew, Porter, David L, Shea, Thomas C, Boyer, Michael W, Maziarz, Richard T, Shaughnessy, Paul J, Gergis, Usama, Safah, Hana, Reshef, Ran, DiPersio, John F, Stiff, Patrick J, Vusirikala, Madhuri, Szer, Jeff, Holter, Jennifer, Levine, James D, Martin, Paul J, Pidala, Joseph A, Lewis, Ian D, Ho, Vincent T, Alyea, Edwin P, Ritz, Jerome, Glavin, Frank, Westervelt, Peter, Jagasia, Madan H, Chen, Yi-Bin

“…Purpose Several open-label randomized studies have suggested that in vivo T-cell depletion with anti-T-lymphocyte globulin (ATLG; formerly antithymocyte…”
Get full text

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease by Martin, Paul J., Storer, Barry E., Rowley, Scott D., Flowers, Mary E.D., Lee, Stephanie J., Carpenter, Paul A., Wingard, John R., Shaughnessy, Paul J., DeVetten, Marcel P., Jagasia, Madan, Fay, Joseph W., van Besien, Koen, Gupta, Vikas, Kitko, Carrie, Johnston, Laura J., Maziarz, Richard T., Arora, Mukta, Jacobson, Pamala A., Weisdorf, Daniel

“…We conducted a double-blind, randomized multicenter trial to determine whether the addition of mycophenolate mofetil (MMF) improves the efficacy of initial…”
Get full text

Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count‐driven approach by Horowitz, Justin G., Gawrys, Gerard W., Lee, Grace C., Ramirez, Brittney A., Elledge, Carole M., Shaughnessy, Paul J.

“…Background Autologous hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of developing life‐threatening infections. There is…”
Get full text

First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation by Martin, Paul J, Rizzo, J. Douglas, Wingard, John R, Ballen, Karen, Curtin, Peter T, Cutler, Corey, Litzow, Mark R, Nieto, Yago, Savani, Bipin N, Schriber, Jeffrey R, Shaughnessy, Paul J, Wall, Donna A, Carpenter, Paul A

“…Despite prophylaxis with immunosuppressive agents or a variety of other approaches, many patients suffer from acute graft-versus-host disease (aGVHD) after…”
Get full text

Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations by Giralt, Sergio, Costa, Luciano, Schriber, Jeffrey, DiPersio, John, Maziarz, Richard, McCarty, John, Shaughnessy, Paul, Snyder, Edward, Bensinger, William, Copelan, Edward, Hosing, Chitra, Negrin, Robert, Petersen, Finn Bo, Rondelli, Damiano, Soiffer, Robert, Leather, Helen, Pazzalia, Amy, Devine, Steven

“…Abstract Autologous hematopoietic stem cell transplantation (aHSCT) is a well-established treatment for malignancies such as multiple myeloma (MM) and…”
Get full text

S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE‐CEL), A FAST‐OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B‐CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY by Roddie, Claire, Sandhu, Karamjeet, Tholouli, Eleni, Shaughnessy, Paul, Barba Suñol, Pere, Nuno Direito de Morais Guerreiro, Manuel, Abedi, Mehrdad, Bishop, Michael, Yared, Jean, Ghobadi, Armin, Yallop, Deborah, Logan, Aaron, Amer, Beitinjaneh, Pantin, Jeremy, Arellano, Martha L, Chaganti, Sridhar, Malladi, Ram, Menne, Tobias, Escamilla, Virginia, Hodby, Katharine, Gundabolu, Krishna, Mountjoy, Luke, Odwyer, Kristen, Abedin, Sameem, Alkhateeb, Hassan, Shah, Bijal, Basilico, Silvia, Cluxton, Deborah, Dawes, Joanna, Lao‐Sirieix, Pierre, Raymond, Meera, Shang, Justin, Hu, Yanqing, Pittari, Gianfranco, Saxena, Kapil, Brugger, Wolfram, Zhang, Y, Pule, Martin, Park, Daniel, De Angelo, Daniel, Jabbour, Elias

Get full text

Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation by Duong, Hien K, Savani, Bipin N, Copelan, Ed, Devine, Steven, Costa, Luciano J, Wingard, John R, Shaughnessy, Paul, Majhail, Navneet, Perales, Miguel-Angel, Cutler, Corey S, Bensinger, William, Litzow, Mark R, Mohty, Mohamad, Champlin, Richard E, Leather, Helen, Giralt, Sergio, Carpenter, Paul A

“…Abstract Peripheral blood progenitor cell mobilization practices vary significantly among institutions. Effective mobilization regimens include growth factor…”
Get full text

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee by Palmer, Jeanne, McCune, Jeannine S, Perales, Miguel-Angel, Marks, David, Bubalo, Joseph, Mohty, Mohamad, Wingard, John R, Paci, Angelo, Hassan, Moustapha, Bredeson, Christopher, Pidala, Joseph, Shah, Nina, Shaughnessy, Paul, Majhail, Navneet, Schriber, Jeff, Savani, Bipin N, Carpenter, Paul A

“…Abstract The Practice Guidelines Committee of the American Society of Blood or Marrow Transplantation (ASBMT) sought to develop an evidence-based review about…”
Get full text

Pushing the limits of successful mobilization of autologous hematopoietic stem cells by Shaughnessy, Paul

Get full text

Lymphocyte Subset Recovery Pattern and Incidence of Infectious Disease after Allogeneic Hematopoietic Stem Cell Transplant by Wangjam, Tamna, Shaughnessy, Paul J, Zoghi, Behyar

Get full text

Granulocyte Colony‐Stimulating Factor Mobilizes More Dendritic Cell Subsets Than Granulocyte‐Macrophage Colony‐Stimulating Factor with No Polarization of Dendritic Cell Subsets in Normal Donors by Shaughnessy, Paul J., Bachier, Carlos, LeMaistre, Charles F., Akay, Cagla, Pollock, Brad H., Gazitt, Yair

“…Dendritic cells (DCs) are effective antigen‐presenting cells. We hypothesized that increasing the DC populations in donor lymphocyte infusions (DLIs) may…”
Get full text

ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors by Hashmi, Shahrukh K., Lee, Stephanie J., Savani, Bipin N., Burns, Linda, Wingard, John R., Perales, Miguel-Angel, Palmer, Jeanne, Chow, Eric, Meyer, Everett, Marks, David, Mohty, Mohamad, Inamoto, Yoshihiro, Rodriguez, Cesar, Nagler, Arnon, Sauter, Craig, Komanduri, Krishna V., Pidala, Joseph, Hamadani, Mehdi, Johnston, Laura, Shah, Nina, Shaughnessy, Paul, Hamilton, Betty K., Majhail, Navneet, Kharfan-Dabaja, Mohamed A., Schriber, Jeff, DeFilipp, Zachariah, Tarlock, Katherine G., Fanning, Suzanne, Curtin, Peter, Rizzo, J. Douglas, Carpenter, Paul A.

“…Significant advances in hematopoietic cell transplantation (HCT) have increased the long-term survivorship of its recipients, but because of unique…”
Get full text

Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIG by Bachier, Carlos, Helmer, Richard, Lyons, Roger M., Shaughnessy, Paul, Zoghi, Behyar, LeMaistre, C. Frederick

“…The use of high dose chemotherapy followed by autologous hematopoietic stem cell transplantation for remission consolidation after initial induction represents…”
Get full text

Once daily busulfan cyclophosphamide is well tolerated and effective as a preparative regimen for allogeneic hematopoietic stem cell transplant by LeMaistre, Julia A, Bachier, Carlos, Smith, Bradley, LeMaistre, CF, Shaughnessy, Paul J

“…We report a retrospective review of our institutional data using once daily intravenous (IV) busulfan (Bu) and cyclophosphamide (Cy) and total body irradiation…”
Get full text

Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial by Gooptu, Mahasweta, Kim, Haesook.T., Chen, Yi-Bin, Rybka, Witold, Artz, Andrew, Boyer, Michael, Johnston, Laura, McGuirk, Joseph, Shea, Thomas C., Jagasia, Madan, Shaughnessy, Paul J., Reynolds, Carol G., Fields, Marie, Alyea, Edwin P., Ho, Vincent. T., Glavin, Frank, Dipersio, John F., Westervelt, Peter, Ritz, Jerome, Soiffer, Robert J.

“…We recently conducted a randomized double-blind study in which we demonstrated that moderate/severe chronic graft-versus-host disease (cGVHD) but not…”
Get full text

Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation by Elayan, Mohammed M, Horowitz, Justin G, Magraner, Jose M, Shaughnessy, Paul J, Bachier, Carlos

“…Abstract There are limited data available supporting the use of the recombinant granulocyte colony–stimulating factor (G-CSF), tbo-filgrastim, rather than…”
Get full text

Seventy Nine Miles, Two Sites and One Fact Accreditation: Integrating Effective Quality Management Between Two Affiliated but Physically Remote Hematopoietic Cellular Transplantation (HCT) Facilities by Cantwell, Lisa, Dodd, Therese, Ramakrishnan, Aravind, Ratliff, Kimberlie, Shaughnessy, Paul J

Get full text

Four Days Tbo-Filgrastim Mobilization for Autologous Transplantation Demonstrates Similar CD34+ Yields and Less Use of Plerixafor by Cantwell, Lisa, Malik, Shahbaz, Duran, Rose, Collins, Keri, Blunk, Betsy, Ramakrishnan, Aravind, Shaughnessy, Paul J

Get full text

Improving Survival Outcomes for Hematopoietic Cellular Transplant (HCT) Recipients by Shaughnessy, Paul J, Cruz, Jose C, Lex, Richard, Shade, Sherri, Ratliff, Kimberlie

Get full text

End of Life Issues for AYA Patients Post Allogeneic Hematopoietic Stem Cell Transplants by Naik, Seema, Quigg, Troy C, Bajorek, Ellen, Shaughnessy, Paul J, Estrada, Jaime

Get full text